跳至主要内容
临床试验/NCT00465257
NCT00465257暂停4 期

Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction as New Treatment Policy for Uncomplicated Plasmodium Falciparum Malaria in Zanzibar

Karolinska University Hospital1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2007年5月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
暂停
发起方
入组人数
110
试验地点
1
主要终点
PCR adjusted parasitological cure rate by day 42.

研究概览

简要总结

The purpose of this study is to assess the efficacy of artesuante + amodiaquine four years after its introduction as first line treatment for uncomplicated childhood malaria in Zanzibar. The hypothesis is that the treatment has a polymerase chain reaction (PCR)adjusted parasitological cure rate of at least 85% 42 days after treatment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
盲法
None

入排标准

年龄范围
6 Months 至 59 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Age below 60 months
  • Weight ≥5kg
  • No general danger signs or severe malaria present (see 4.4.2.1 & 4.4.2.2)
  • History of fever within 24 hours OR axillary temperature ≥ 37.5Cº
  • No other cause of fever is detectable
  • No severe malnutrition
  • Presence of P. falciparum asexual parasite density between 2000- 200,000/ul
  • Guardian/Patient has understood the procedures of the study and is willing to participate
  • Patient able to come for stipulated follow up visits and has easy access to the Study Site

排除标准

  • Not able to drink or breastfeed
  • Persistent Vomiting
  • Recent history of convulsions
  • Lethargic or unconscious
  • Unable to sit or stand (as appropriate for age)
  • History of allergy to test drugs
  • History of intake of any drugs other than paracetamol and aspirin within 3 days

结局指标

主要结局

PCR adjusted parasitological cure rate by day 42.

次要结局

未报告次要终点

研究者

发起方
Karolinska University Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验